Does ALDESLEUKIN Cause Malignant neoplasm progression? 31 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Malignant neoplasm progression have been filed in association with ALDESLEUKIN (GUNA-VIRUS). This represents 3.7% of all adverse event reports for ALDESLEUKIN.
31
Reports of Malignant neoplasm progression with ALDESLEUKIN
3.7%
of all ALDESLEUKIN reports
11
Deaths
4
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ALDESLEUKIN?
Of the 31 reports, 11 (35.5%) resulted in death, 4 (12.9%) required hospitalization, and 1 (3.2%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALDESLEUKIN. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does ALDESLEUKIN Cause?
Pyrexia (112)
Off label use (105)
Pain (76)
Hypotension (62)
Drug ineffective (53)
Thrombocytopenia (52)
Hypoxia (47)
Fatigue (46)
Chills (45)
Acute kidney injury (41)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ALDESLEUKIN Alternatives Have Lower Malignant neoplasm progression Risk?
ALDESLEUKIN vs ALECTINIB
ALDESLEUKIN vs ALEMTUZUMAB
ALDESLEUKIN vs ALENDRONATE
ALDESLEUKIN vs ALENDRONATE\CHOLECALCIFEROL
ALDESLEUKIN vs ALENDRONIC ACID